Neuroprotective and anti-amnesic potentials of sigma (σ) receptor ligands

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 21, Issue 1, 1997, Pages 69-102

  Maurice, Tangui ^a,c   Lockhart, Brian P ^b  

^a INSERM   (France)

^b INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^c INSTITUT CHARLES GERHARDT   (France)

Author keywords

cholinergic systems; ischemia; learning and memory; N methyl D aspartate receptor complex; neuroactive steroids; neuropeptide Y; neuroprotection

Indexed keywords

2 [4 METHOXY 3 (2 PHENYLETHOXY)PHENYL] N,N DIPROPYLETHYLAMINE; ALPHA (4 FLUOROPHENYL) 4 (5 FLUORO 2 PYRIMIDINYL) 1 PIPERAZINEBUTANOL; CALCITONIN GENE RELATED PEPTIDE; CYCLAZOCINE; DEXTROMETHORPHAN; DEXTRORPHAN; DIZOCILPINE; ELIPRODIL; FENPROPIMORPH; HALOPERIDOL; IFENPRODIL; IGMESINE; LEVORPHANOL; N ALLYLNORMETAZOCINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROPEPTIDE Y; NIMODIPINE; OPIPRAMOL; PENTAZOCINE; PENTOXYVERINE; PHENCYCLIDINE; RIMCAZOLE; SABELUZOLE; SIGMA OPIATE RECEPTOR;

AMNESIA; ANIMAL EXPERIMENT; BRAIN ISCHEMIA; CHOLINERGIC SYSTEM; COGNITION; CONVULSION; ELECTROPHYSIOLOGY; HIPPOCAMPUS; LEARNING; MEMORY; MOUSE; NEUROPROTECTION; NONHUMAN; RAT; REVIEW;

AMNESIA; ANIMALS; LIGANDS; MICE; NEUROPROTECTIVE AGENTS; RECEPTORS, SIGMA;

EID: 0030951630     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(96)00160-1     Document Type: Review

References (215)

1. BARTUS, R.T., DEAN, I.L., BEER, B. and LIPPA, A. (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217: 408-417.
2. 3H]pentazocine binding to guinea-pig cerebellum by divalent cations. Mol. Pharmacol. 42: 882-889.
3. BELL, J.A., SPIVAK, C.E., SU, T.P. and LONDON, E.D. (1988) Haloperidol-sensitive, selective electrophysiological effects of sigma ligands on NCB-20 cells. Soc. Neurosci. Abstr. 14: 1155.
4. BENVENISTE, H., DREJER, J., SCHOUSBOUE, A. and DIEMER, N.H. (1984) Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43: 1369-1374.
5. BERGERON, R., DE MONTIGNY, C. and DEBONNEL, G. (1996) Potentiation of neuronal response induced by dehydroepiandrosterone and its suppression by progesterone: Effects mediated via sigma receptors. J. Neurosci. 16: 1193-1202.
6. BOLOGNA, L., SHARMA, J. and ROBERTS, E. (1987) Dehydroepiandrosterone and its sulfated derivative reduce neuronal cell death and enhance astrocytic differentiation in brain cell cultures. J. Neurosci. Res. 17: 225-234.
7. BOSLEY, T.M., WOODHAMS, P.L., GORDON, R.D. and BALAZS, R. (1983) Effects of anoxia on the stimulated release of amino acid neurotransmitters in the cerebellum in vitro. J. Neurochem. 40: 189-201.
8. BOUCHARD, P., DUMONT, Y., FOURNIER, A., ST-PIERRE, S. and QUIRION, R. (1993) Evidence for in vivo interactions between Neuropeptide Y-related peptides and σ receptors in the mouse hippocampal formation. J. Neurosci. 13: 3926-3931.
9. BOUCHARD, P., MAURICE, T., ST-PIERRE, S., PRIVAT, A. and QUIRION, R. (1995a) Neuropeptide Y and Calcitonin-Gene-Related-Peptide attenuate memory impairment induced by MK-801 by a sigma receptor-related mechanism. Soc. Neurosci. Abstr. 21: 1233.
10. BOUCHARD, P., MONNET, F., BERGERON, R., ROMAN, F., JUNIEN, J.L., De MONTIGNY, C., DEBONNEL, G. and QUIRION, R. (1995b) In vivo modulation of sigma receptor sites by calcitonin gene-related peptide in the mouse and rat hippocampal formation: Radioligand binding and electrophysiological studies. Eur. J. Neurosci. 7: 1952-1962.
11. BOUCHARD, P., ROMAN, F., JUNIEN, J.L. and QUIRION, R. (1996) Autoradiographic evidence for the modulation of in vivo sigma receptor labelling by neuropeptide Y and calcitonin gene-related peptide in the mouse brain. J. Pharmacol. Exp. Ther. 276: 223-230.
12. BOWLBY, M.R. (1993) Pregnenolone sulfate potentiation of N-Methyl-D-aspartate receptor channels in hippocampal neurons. Mol. Pharmacol. 43: 813-819.
13. BRENT, P.J., HAYNES, H., JARVIE, P.E., MUDGE, L., SIM, A.T. and DUNKLEY, P.R. (1995) Phosphorylation of synapsin I and dynamin in rat forebrain synaptosomes: Modulation by sigma (σ) ligands. Neurosci. Lett. 191: 71-74.
14. 1 ligands. J. Med. Chem. 37: 2285-2291.
15. CAMBELL, B.G., KEANA, J.F.W. and WEBER, E. (1991) σ Receptor ligand N,N′-di-(orthotolyl)guanidine inhibits release of acetylcholine in the guinea pig ileum. Eur. J. Pharmacol. 205: 219-223.
16. CHENEY, D.L., UZUNOV, D. and GUIDOTTI, A. (1995) Pregnenolone sulfate antagonizes dizocilpine amnesia: Role for allopregnanolone. Neuroreport 6: 1697-1700.
17. CHOI, D.W., KOH, J.Y. and PETERS, S. (1988) Pharmacology of glutamate neurotoxicity in cortical cell culture: Attenuation by NMDA antagonists. J. Neurosci. 8: 185-196.
18. CHOI, D.W., MAULUCCI,-GEDDE, M.A. and KRIEGSTEIN, A.R. (1987a) Glutamate neurotoxicity in cortical in cell culture. J. Neurosci. 7: 357-368.
19. CHOI, D.W., PETERS, S. and VISESKUL, V. (1987b) Dextrorphan and levorphanol selectively block N-methyl-D-aspartate receptor-mediated neurotoxicity on cortical neurons. J. Pharmacol. Exp. Ther. 242: 713-720.
20. CLISSOLD, D.B., PONTECORVO, M.J., JONES, B.E., ABREU, M.E., KARBON, E.W., ERICKSON, R.H., NATALIE JR. K.J., BOROSKY, S., HARTMAN, T., MANSBACH, R.S., BALSTER, R.L., FERKANY, J.W. and ENNA, S.J. (1993) NPC 16377, a potent and selective σ-ligand. II. Behavioural and neuroprotective profile. J. Pharmacol. Exp. Ther. 265: 876-883.
21. COLLINGRIDGE, G.L., KEHL, S.J. and McLENNAN, H. (1983) Excitatory amino acids in synaptic transmission in the Schaffer collateral-commissural pathway of the rat hippocampus. J. Physiol. (Lond.) 334: 33-46.
22. CONTRERAS, P.C., CONTRERAS, M.L., O'DONOHUE, T.L. and LAIR, C.C. (1988) Biochemical and behavioral effects of sigma and PCP ligands. Synapse 2: 240-243.
23. CONTRERAS, P.C., GRAY, N., RAGAN, D. A and LANTHORN, T. (1992) BMY-14802 protects against ischemia-induced neuronal damage in the gerbil. Life Sci. 51: 1143-1151.
24. CONTRERAS, P.C., RAGAN, D.M., BREMER, M.E., LANTHORN, T.H., GRAY, N.M., IYENGAR, S., JACOBSON, A.E., RICE, K.C. and DE COSTA, B.R. (1991) Evaluation of U-50, 488H analogs for neuroprotective activity in the gerbil. Brain Res. 546: 79-82.
25. COOK, L., TAM, S.W. and ROHRBACH, K.W. (1992) DuP 734 [1-(cyclopropylmethyl)-4-(2'(4"-fluorophenyl)-2'-oxoethyl)piperidine Hbr], a potential antipsychotic agent: Preclinical behavioral effects. J. Pharmacol. Exp. Ther. 263: 1159-1166.
26. COURTNEY, M.J., LAMBERT, J.J. and NICHOLLS, D.G. (1990) The interactions between plasma membrane depolarization and glutamate receptor activation in the regulation of cytoplasmic free calcium in cultured cerebellar granule cells. J. Neurosci. 10: 3873-3879.
27. DANYSZ, W. and WROBLEWSKI, J.T. (1989) Amnesic properties of glutamate receptor antagonists. Neurosci. Res. Commun. 5: 9-18.
28. DAVIDSON, J., DREN, A.T., MILLER, R., MANBERG, P., KILTS, C. and WINGFIELD, M (1985) BW234U: A nondopamine receptor-blocking antipsychotic drug without extrapyramidal side-effects? Drug Dev. Res. 6: 13-17.
29. DAVIES, P. and MALONEY, A.J.F. (1976) Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 2: 1403.
30. DELOORE, K., LESAGE, A.S., PEETERS, L. and LEYSEN, J.E. (1994) Various sigma ligands exert long-term protection against glutamate toxicity in primary hippocampal neurons; Apparent non involvement of identified sigma-2 sites. Neurosci. Res. Commun. 14: 43-51.
31. 2 ligands. Soc. Neurosci. Abstr. 21: 1609.
32. DECKER, M.W. and McGAUGH, J.L. (1991) The role of interactions between the cholinergic system and other neuromodulatory systems in learning and memory. Synapse 7: 151-168.
33. DECOSTER, M.A., KLETTE, K.L., KNIGHT, E.S. and TORTELLA, F.C. (1995) a receptor-mediated neuroprotection against glutamate toxicity in primary rat neuronal cultures. Brain Res. 671: 45-53.
34. DEN BOER, J.A., RAVELLI, D.P., HUISMAN, J., OHRVIK, J., VERHOEVEN, W.M.A. and WESTENBERG, H.G.M. (1990) Double blind comparative study of remoxipride and haloperidol in schizophrenic patients. Psychopharmacology 102: 76-84.
35. DOKLA, C.P.J., PARKER, S.C. and THAL, L.J. (1989) Tetrahydroaminoacridine facilitates passive avoidance learning in rats with nucleus basalis magnocellularis lesions. Neuropharmacology 28: 1279-1284.
36. DRACHMAN, D.A. and LEAVITT, J. (1974) Human memory and the cholinergic system: A relationship to aging? Arch. Neurol. 30: 113-121.
37. DREJER, J., BENVENISTE, H., DIEMER, N.H. and SCHOUSBOE, A (1985) Cellular origin of ischaemic-induced glutamate release from brain tissue in vivo and in vitro. J. Neurochem. 45: 145-151.
38. EARLEY, B., BURKE, M., LEONARD, B.E., GOURET, C.J. and JUNIEN, J.L. (1991) Evidence for an anti-amnesic effect of JO-1784 in the rat: A potent and selective ligand for the sigma receptor. Brain Res. 546: 282-286.
39. EARLEY, B., CANNEY, M., O'NEILL, M., LEONARD, B.E., BENICOURT, C. and JUNIEN, J.L. (1993) Experimental cerebral ischemia in Mongolian gerbils: Effects of JO-1784 on histological parameters and locomotor activity. Soc. Neurosci. Abstr. 19: 1644.
40. EARLEY, B., GLENNON, M., CANE, D., LEONARD, B.E. and JUNIEN, J.L. (1995) Behavioural evidences for a modulatory role of the σ ligands JO-1784 and 2-DTG in memory processes in the rat. Soc. Neurosci. Abstr. 21: 1233.
41. ++ influx and beating rate in cultured cardiac myocytes. J. Pharmacol. Exp. Ther. 269: 1300-1309.
42. ELLIS, Y. and DAVIES, J.A. (1994) The effects of sigma ligands on the release of glutamate from rat striatal slices. Arch. Pharmacol. 350: 143-148.
43. EVANS, MC., SWAN, J.H. and MELDRUM, B.S. (1987) An adenosine analogue, 2-chloroadenosine, protects against long term development of ischaemic cell loss in the rat. Neurosci. Lett. 83: 287-292.
44. FAHEY, J.M., LINDQUIST, D.G., PRITCHARD, G.A. and MILLER, L.G. (1995) Prenenolone sulfate potentiation of NMDA-mediated increases in intracellular calcium in cultured chick cortical neurons. Brain Res. 669: 183-188.
45. FARLOW, M., GRACON, S.I., HERSHEY, L.A., LEWIS, K.W., SANDOWSKY, C.H. and DOLAN-URENO, J. (1992) A controlled trial of tacrine in Alzheimer's disease. J. Am. Med. Assoc. 268: 2523-2529.
46. 1 neurons via a pertussis toxin-sensitive G-protein-coupled mechanism. J. Neurosci. 14: 1963-1977.
47. FINNEGAN, K.T., KERR, J.T. and LANGSTON, J.W. (1991) Dextromethorphan protects against the neurotoxic effects of p-chloroamphetamine in rats. Brain Res. 558: 109-113.
48. FLETCHER, E.J. and MACDONALD, J.F. (1993) Haloperidol interacts with the strychnine-insensitive glycine site at the NMDA receptor in cultured mouse hippocampal neurones. Eur. J. Pharmacol. 235: 291-295.
49. FLOOD, J.F. and CHERKIN, A. (1986) Scopolamine effects on memory retention in mice: A model of dementia ? Behav. Neural Biol. 45: 169-184.
50. FLOOD, J.F. and MORLEY, J.E. (1992) Early onset of age-related impairment of aversive and appetitive learning in the SAM-P/8 mouse. J. Geront. 47: B52-B59.
51. FLOOD, J.F. and MORLEY, J.E. (1993) Age-related changes in footshock avoidance acquisition and retention in senescence accelerated mouse (SAM). Neurobiol. Aging 14: 153-157.
52. FLOOD, J.F. and ROBERTS, E. (1988) Dehydroepiandrosterone sulfate improves memory in aging mice. Brain Res. 448: 178-181.
53. FLOOD, J.F., MORLEY, J.E. and LA REGINNA, M. (1993) Age-related changes in the pharmacological improvement of retention in senescence accelerated mouse (SAM). Neurobiol. Aging 14: 159-166.
54. FLOOD, J.F., MORLEY, J.E. and ROBERTS, E. (1992) Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it. Proc. Natl. Acad. Sci. USA 89: 1567-1571.
55. GLICK, S.D. and ZIMMERBERG, B. (1972) Amnesic effects of scopolamine. Behav. Biol. 7: 245-254.
56. GOLDBERG, M.P., PHAM, P.C. and CHOI, D.W. (1987b) Dextorphan and dextromethorphan block anoxic neuronal injury in culture. Neurology 37: 250.
57. GOLDBERG, M.P., WEISS, J.H., PHAM, P. and CHOI, D.W. (1987a) N-methyl-D-aspartate receptors mediates hypoxic neuronal injury in cortical culture. J. Pharmacol. Exp. Ther. 243: 784-789.
58. GRAHAM, D., DARLES, G. and LANGER, S.Z. (1992) The neuroprotective properties of ifenprodil, a novel NMDA receptor antagonist, in neuronal cell culture toxicity studies. Eur. J. Pharmacol. 226: 373-376.
59. GROVER, L.M. and TEYLER, T.J. (1990) Two components of long-term potentiation induced by different patterns of afferent activation. Nature 347: 477-479.
60. GUNDLACH, A.L., LARGENT, B.L. and SNYDER, S.L. (1985) Phencyclidine and sigma opiate receptors in brain: Biochemical and autoradiographical differentiation. Eur. J. Pharmacol. 113: 465-466.
61. 3H-Phencyclidine in brain membranes. Life Sci. 30: 2147-2154.
62. 1-binding site. Proc. Natl. Acad. Sci. USA 93: 8072-8077.
63. 2+ antagonist binding protein. J. Biol. Chem. 270: 7551-7557.
64. 2+ channels in the induction of LTP. J. Neurosci. 13: 568-576.
65. ++ responses: Structure-activity studies. J. Pharmacol. Exp. Ther. 271: 677-682.
66. 2+ in cultured rat hippocampal neurons. Neurosci. Lett. 141: 30-34.
67. ISHIMARU, H., KATOH, A., SUZUKI, H., FUKUTA, T., KAMEYAMA, T. and NABESHIMA, T. (1992) Effect of N-methyl-D-aspartate receptor antagonists on carbon monoxide-induced brain damage in mice. J. Pharmacol. Exp. Ther. 261: 349-352.
68. ISHIMARU, H., NABESHIMA, T., KATOH, A., SUZUKI, H., FUKUTA, T. and KAMEYAMA, T. (1991) Effect of successive carbon monoxide exposures on delayed neuronal death in mice under the maintenance of normal boby temperature. Biochem. Biophys. Res. Commun. 179: 836-840.
69. ITZHAK, Y. (1989) Multiple affinity binding states of the sigma receptor: Effect of GTP-binding protein modifying agents. Mol. Pharmacol. 36: 512-517.
70. ITZHAK, Y. (1994) Sigma receptors. Academic Press, San Diego, CA.
71. ITZHAK, Y. and ALERHAND, S. (1989) Differential regulation of σ and PCP receptors after chronic administration of haloperidol and phencyclidine in mice. FASEB J. 3: 1868-1872.
72. 10 dopaminergic neurotensin the rat brain: Functional interaction with NMDA receptors. Brain Res. 524: 322-326.
73. IYENGAR, S., MICK, S., DILWORTH, V., MICHEL, J., RAO, T.S., FARAH, J.M. and WOOD, P.L. (1990a) Sigma receptors modulate the hypothalamic-pituitary-adrenal (HPA) axis centrally: Evidence for a functional interaction with NMDA receptors, in vivo. Neuropharmacology 29: 299-303.
74. IYENGAR, S., WOOD, P.L., MICK, S., DILWORTH, V., GRAY, N.M., FARAH, J.M., RAO, T.S. and CONTRERAS, P.C. (1991) (+)3-[3-Hydroxyphenyl-N-(1-propyl) piperidine] selectively differentiates effects of sigma ligands on neurochemical pathways modulated by sigma receptors: Evidence for subtypes, in vivo. Neuropharmacology 30: 915-922.
75. JONES, S.M., SNELL, L.D. and JOHNSON, K.M. (1987) Inhibition by phencyclidine of excitatory amino acid-stimulated release of neurotransmitter in the nucleus accumbens. Neuropharmacology 26: 173-179.
76. 3H]acetylcholine release from rat hippocampal slices. Eur. J. Pharmacol. 200: 343-345.
77. KAISER, C., PONTECORVO, J. and MEWSHAW, R. (1991) Sigma receptor ligands: Function and activity. Neurotransmissions 7: 1-22.
78. KAMEI, J., IWAMOTO, Y., KAWASHIMA, N., HITOSUGI, H., MISAWA, M. and KASUYA, Y. (1992) Involvement of haloperidol-sensitive σ-sites in antitussive effects. Eur. J. Pharmacol. 224: 39-43.
79. KARBON, E.W., ABREU, M.E., ERICKSON, R.H., KAISER, C., NATALIE, K.J., CLISSOLD, D.B., BOROSKY, S., BAILEY, M., MARTIN, L.A., PONTECORVO, M.J., ENNA, S.J. and FERKANY, J.W. (1993) NPC-16377, a potent and selective a ligand. I. Receptor binding, neurochemical and neuuroendocrine profile. J. Pharmacol. Exp. Ther. 265: 866-875.
80. 3H]-PPP-labelled σ binding sites in guinea-pig brain membranes. Eur. J. Pharmacol. 176: 247-248.
81. KIRK, C.J., REDDY, N.L., FISCHER, J.B., WOLCOTT, T.C., KNAPP, A.G. and MCBURNEY, R.N. (1994) In vitro neuroprotection by substituted guanidines with varying affinities for the N-methyl-D-aspartate receptor ionophore and for sigma sites. J. Pharmacol. Exp. Ther. 271: 1080-1085.
82. KITAICHI, K., HASEGAWA, T., FURUKAWA, H. and NABESHIMA, T. (1994) Sigma ligands modulate MK-801-induced hyperlocomotion and head-weaving in rats. Jpn. J. Pharmacol. 64S1: 358P.
83. 3H]nitrenpidine to cerebral cortical and hippocampal membranes of senescence accelarated mouse. Neurosci. Lett. 106: 334-338.
84. 3H]dextromethorphen and sigma ligands to guinea-pig brain. In: Sigma Receptors, Y. Itzhak (Ed.), pp 243-262, Academic Press, San Diego, CA.
85. KLETTE, K.L., DECOSTER, M.A., MORETON, J.E. and TORTELLA, F.A. (1995) Role of calcium in sigma-mediated neuroprotection in rat primary cortical neurons. Brain Res. 704: 31-41.
86. KNIGHT, A.R., NOBLE, A., WONG, E.H.F. and MIDDLEMISS, D.N. (1991) The subcellular distribution and pharmacoloy of the sigma recognition site in the guinea-pig brain and liver. Mol. Neuropharmacol. 1: 71-75.
87. LAMBERT., P.D., WOODRUFF, G.N., HUGHES, J. and HUNTER, J.C. (1991) Inhibition of L-glutamate release: A possible mechanism of action for the neuroprotective effects of the K-selective agonist CI-977. Mol. Neuropharmacol. 1: 77-82.
88. 3H]3-PPP. Eur. J. Pharmacol. 124: 183-187.
89. LEVANT, B. and NEMEROFF, C.B. (1990) Sigma receptor "antagonists" BMY 14802 increases neurotensin concentrations in the rat nucleus accumbens and caudate. J. Pharmacol. Exp. Ther. 254: 330-335.
90. LEVIN, E.D., MCGURK, S.R., SOUTH, D. and BUTCHER, L.L. (1989) Effects of combined muscarinic and nicotinic blockade on choice accuracy in the radial-arm maze. Behav. Neural Biol. 51: 270-277.
91. LIU, D. and MCADOO, D.J. (1993) Methylprednisolone reduces excitatory amino acid release following experimental spinal cord injury. Brain Res. 609: 293-297.
92. LIU, J.P., SIM, A.T.R. and ROBINSON, P.J. (1994) Calcineurin inhibition of dynamin I GTPase activity coupled to nerve terminal depolarization.Science 265: 970-973
93. LOBNER, D. and LIPTON, P. (1990) Sigma ligands and non-competitive NMDA antagonists inhibit glutamate release during cerebral ischemia. Neurosci. Lett. 117: 169-174.
94. LOCKHART, B.P., SOULARD, P., BENICOURT, C., PRIVAT, A. and JUNIEN, J.L. (1995) Distinct neuroprotective profiles for σ ligands against N-methyl-D-aspartate (NMDA), and hypoxia-mediated neurotoxicity in neuronal culture toxicity studies. Brain Res. 675: 110-120.
95. LODGE, D. and JOHNSTON, G.A.R. (1985) Effect of ketamine on amino acid-evoked release from rat cerebral cortex in vitro. Neurosci. Lett. 56: 371-375.
96. LONG, J.B., KRAIMER, J.M., TIDWELL, R.E., RICE, K.C. and DE COSTA, B.R. (1990) Dexhromathorphan and BD737, a novel highly selective σ ligand, protects against dynorphin A induced rat spinal cord injury. Eur. J. Pharmacol. 183: 961.
97. LONG, J.B., OLESHANSKY, M.A. and DE COSTA, B.R. (1992) Selective a ligands protect against spinal cord injury in rats: In vivo and in vitro evidence. In: Multiple Sigma and PCP Receptor Ligands: Mechanisms for Neuromodulation and Neuroprotection?, J.M. Kamenka and E.F. Domino (Eds.), pp 673-686, NPP Books, Ann Arbor, MI.
98. LYSKO, P.G. and FEUERSTEIN, G. (1990) Excitatory amino acid neurotoxicity at the N-methyl-D-aspartate receptor in cultured neurons: Protection by SKF-10,047. Neurosci. Lett. 120: 217-220.
99. LYSKO, P.G., CAGNON, R.C., YUE, T.L., GU, J.L. and FEUERSTEIN, G. (1992a) Neuroprotective effects of SKF-10,047 in cultured rat cerebellar neurons and in gerbil global brain ischemia. Stroke 23: 414-419.
100. LYSKO, P.G., YUE, T.L., GU, J.L. and FEUERSTEIN, G. (1992b) Neuroprotective mechanism of (+)-SKF-10,047 in vitro and in gerbil global brain ischemia. Stroke 23: 1319-1323.
101. MACKAY, K.B., KUSUINOTO, K. and MCCULLOCH, J. (1991) The neuroprotective effect of the kappa agonist CI-977 in a rat model of focal brain ischemia. Br. J. Pharmacol. 104: 303P.
102. MAIONE, S., BERRINO, L., VITAGLIANO, S., LEYVA, J. and ROSSI, F. (1992) Pregnenolone sulfate increases the convulsant potency of N-methyl-D-aspartate in mice. Eur. J. Pharmacol. 219: 477-479.
103. MAJEWSKA, M.D. and SCHWARTZ, R.D. (1987) Pregnenolone-sulfate: an endogenous antagonist of the γ-aminobutyric acid receptor complex in brain ? Brain Res. 404: 355-360.
104. A receptor. Brain Res. 526: 143-146.
105. MAJEWSKA, M.D., MIENVILLE, J.M and VICINI, S. (1988) Neurosteroid pregnenolone sulfate antagonizes electrophysiological responses to GABA in neurons. Neurosci. Lett. 90: 279-284.
106. 3H]-N-allylnormetazocine bind to different sites in mouse brain. J. Pharmacol. Exp. Ther. 231: 539-544.
107. MARTIN, W.R., EADES, C.G., THOMPSON, J.A., HUPPLER, R.E. and GILBERT, P.E. (1976) The effects of morphine and nalorphine-like drugs in the non-dependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 197: 517-532.
108. MATHIS, C., PAUL, S.M. and CRAWLEY, J.N. (1994) The neurosteroid pregnenolone sulfate blocks NMDA antagonist-induced deficits in a passive avoidance memory task. Psychopharmacology 116: 201-206.
109. MATSUNO, K., MATSUNAGA, K. and MITA, S. (1992) Increase of extracellular acetylcholine level in rat frontal cortex induced by (+)N-allylnormetazocine as measured by brain microdialysis. Brain Res. 575: 315-319.
110. MATSUNO, K., MATSUNAGA, K., SENDA, T. and MITA, S. (1993a) Increase in extracellular acetylcholine level by sigma ligands in rat frontal cortex. J. Pharmacol. Exp. Ther. 265: 851-859.
111. 1 receptor agonistic properties. Behav. Brain Res. (in press).
112. MATSUNO, K., SENDA, T., MATSUNAGA, K. and MITA, S. (1994) Ameliorating effects of σ receptor ligands on the impairment of passive avoidance tasks in mice: Involvement in the central acetylcholinergic system. Eur. J. Pharmacol. 261: 43-51.
113. 2 antagonists and drug-induced impairment of passive avoidance response in mice: Comparison with acetylcholinesterase inhibitors. Psychopharmacology 112: 134-141.
114. MAURICE, T., BAYLE, J. and PRIVAT, A. (1995a) Learning impairment following acute administration of the calcium channel antagonist nimodipine in mice. Behav. Pharmacol. 6: 167-175.
115. MAURICE, T., HIRAMATSU, M., ITOH, J., KAMEYAMA, T., HASEGAWA, T. and NABESHIMA, T. (1994a) Behavioral evidence for a modulating role of σ ligands in memory processes. I. Attenuation of dizocilpine (MK-801)-induced amnesia. Brain Res. 647: 44-56.
116. MAURICE, T., HIRAMATSU, M., ITOH, J., KAMEYAMA, T., HASEGAWA, T. and NABESHIMA, T. (1994b) Low dose of 1,3-di(2-tolyl)guanidine (DTG) attenuates MK-801-induced spatial working memory impairment in mice. Psychopharmacology 114: 520-522.
117. MAURICE, T., HIRAMATSU, M., KAMEYAMA, T., HASEGAWA, T. and NABESHIMA, T. (1994c) Behavioral evidence for a modulating role of σ ligands in memory processes. II. Reversion of carbon monoxide-induced amnesia. Brain Res. 647: 57-64.
118. 1 receptors. Soc. Neurosci. Abstr. 23: 1587.
119. 1 receptors. Behav. Brain Res. (in press).
120. MAURICE, T., LOCKHART, B.P. and PRIVAT, A. (1996a) Amnesia induced in mice by centrally administered 7-amyloid peptides involves cholinergic dysfunction. Brain Res. 706: 181-193.
121. MAURICE, T., ROMAN, F.J., SU, T.P. and PRIVAT, A. (1996c) Beneficial effects of sigma agonists on the age-related learning impairment in the senescence-accelerated mouse (SAM). Brain Res. (in press).
122. MAURICE, T., SU, T.P., PARISH, D.W. and PRIVAT, A. (1995b) Prevention of nimodipine-induced impairment of learning by the selective σ ligand PRE-084. J. Neural Transm. 102: 1-18.
123. MAURICE, T., SU, T.P., PARISH, D.W., NABESHIMA, T. and PRIVAT, A. (1994d) PRE-084, a σ selective PCP derivative, attenuates MK-801-induced impairment of learning in mice. Pharmacol. Biochem. Behav. 49: 859-869.
124. 3H]SKF-10,047 binding sites (sigma sites) from rat liver membranes. J. Pharmacol. Exp. Ther. 257: 547-554.
125. MCCANN, D.J., RABIN, R.A., RENS-DOMIANO, S. and WINTER, J.C. (1989) Phencyclidine/SKF-10,047 binding sites: Evaluation of function. Pharmacol. Biochem. Behav. 32: 87-94.
126. MCGAUGH, J.L. (1973) Drug facilitation of learning and memory. Annu. Rev. Pharmacol. 13: 229-241.
127. MENDELSOHN, L.G., KALRA, V., JOHNSON, B.G. and KERCHNER, G.A. (1985) Sigma opioid receptor: Characterization and co-identity with the phencyclidine receptor. J. Pharmacol. Exp. Ther. 233: 597-602.
128. MIYAMOTO, M., KIYOTA, Y., YAMAZAKI, N., NAGAOKA, A., MATSUO, T., NAGAWA, Y. and TAKEDA, T. (1986) Age-related changes in learning and memory in the senescence-accelerated mouse (SAM). Physiol. Behav. 38: 399-406.
129. 2+ antagonist binding protein from guinea pig liver endoplasmic reticulum. J. Biol. Chem. 269: 29314-29320.
130. MONNET, F.P. and BAULIEU, E.E. (1995) Pharmacological evidence for an haloperidol-insensitive sigma receptor that modulates the NMDA response in the rat cns. Soc. Neurosci. Abstr. 21: 1609.
131. i/o proteins. Soc. Neurosci. Abstr. 17: 1340.
132. MONNET, F.P., DEBONNEL, G. and DE MONTIGNY, C. (1990b) Neuropeptide Y selectively potentiates N-methyl-D-aspartate-induced neuronal activation. Eur. J. Pharmacol. 182: 207-208.
133. 3 dorsal hippocampus by sigma ligands. J. Pharmacol. Exp. Ther. 261: 123-130.
134. 3 dorsal hippocampus. II. Involvement of a subtype of sigma receptor. J. Pharmacol. Exp. Ther. 263: 1219-1225.
135. MONNET, F.P., DEBONNEL, G., JUNIEN, J.L. and DE MONTIGNY, C. (1990a) N-methyl-D-aspartate-induced neuronal activation is selectively modulated by sigma receptors. Eur. J. Pharmacol. 179: 441-445.
136. 3 dorsal hippocampus. I. Involvement of an atypical neuropeptide Y receptor. J. Pharmacol. Exp. Ther. 263: 1212-1218.
137. 3H]norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus. Proc. Natl. Acad. Sci. USA 92: 3774-3778.
138. MORRIS, R.G.M., ANDERSON, E., LYNCH, G. M. and BAUDRY, M. (1986) Selective impairment of learning and blockage of long-term potentiation by a N-methyl-D-aspartate receptor antagonist, AP5. Nature 319: 774-776.
139. MURRAY, T.F., and LEID, M.E. (1984) Interaction of dextrorotatory opioids with phencyclidine recognition sites in rat brain membranes. Life Sci. 34: 1899-1911.
140. NABESHIMA, K., KATOH, A., ISHIMARU, I., YONEDA, Y., OGITA, K., MURASE, K., OHTSUKA, H., INARI, K., FUKUTA, T. and KAMEYAMA, T. (1991) Carbon monoxide-induced delayed amnesia, delayed neuronal death and change in acetylcholine concentration in mice. J. Pharmacol. Exp. Ther. 256: 378-384.
141. NARITA, N., HASHIMOTO, K., IYO, M., MINABE, Y. and YAMAZAKI, K. (1995) Lack of neuroprotective effect of a receptor ligands in the neurotoxicity of p-chloroamphetamine in rat brain. Eur. J. Pharmacol. 293: 277-280.
142. NICHOLLS, D. and ATTWELL, D. (1990) The release and uptake of excitatory amino acids. Trends Pharmacol. Sci. 11: 462-468.
143. NICHOLLS, R.A., SUPLICK, G.R. and BROWN, J.M. (1994) Calcineurin-mediated protein dephosphorylation in brain nerve terminals regulates the release of glutamate. J. Biol. Chem. 269: 23817-23823.
144. NIKOLAEV, E. and KACZMAREK, L. (1994) Disruption of two-way active avoidance behavior by nimodipine. Pharmacol. Biochem. Behav. 47: 757-759.
145. NISHIMURA, L.M. and BOEGMAN, R.J. (1990) N-methyl-D-aspartate-evoked release of acetylcholine from the spetal/diagonal band of the rat brain. Neurosci. Lett. 115: 259-264.
146. O'NEILL, M., CALDWELL, M., EARLEY, B., CANNEY, M., O'HALLORAN, A., KELLY, J., LEONARD, B.E. and JUNIEN, J.L. (1995) The a receptor ligand JO-1784 (igmesine hydrochloride) is neuroprotective in the gerbil model of global cerebral ischaemia. Eur. J. Pharmacol. 283: 217-225.
147. O'NEILL, M., CANNEY, M., EARLEY, B., JUNIEN, J.L. and LEONARD, B.E. (1996) The novel a ligand JO-1994 protects against ischaemia-induced behavioural changes, cell death and receptor dysfunction in the gerbil. Neurochem. Int. 28: 193-207.
148. O'NEILL, M., EARLEY, B. and LEONARD, B.E. (1994a) MK-801 and BMY 14802 protect against ischaemia-induced cell death in the gerbil hippocampus. Med. Sci. Res. 22: 303-304.
149. O'NEILL, M., EARLEY, B. and LEONARD, B.E. (1994b) Dextromethorphan protects against ischaemia-induced hippocampal neurodegeneration in the gerbil. Med. Sci. Res. 22: 337-338.
150. OGAWA, S., OKUYAMA, S., ARAKI, H. and OTOMO, S. (1994) Effect of NE-100, a novel σ receptor ligand, on phencyclidine-induced cognitive dysfunction. Eur. J. Pharmacol. 263: 9-15.
151. OHNO, M. and WATANABE, S. (1995) Intrahippocampal administration of (+)-SKF 10,047, a sigma ligand, reverses MK-801-induced impairment of working memory in rats. Brain Res. 684: 237-242.
152. OHTA, A., HIRANO, T., YAGI, H., TANAKA, S., HOSOKAWA, M. and TAKEDA, T. (1989) Behavioral characteristics of the SAM-P/8 strain in Sidman active avoidance task. Brain Res. 498: 195-198.
153. OKUYAMA, S., IMAGAWA, I., OGAWA, S., ARAKI, H., TANAKA, M., MURAMATSU, M. and OTOMO, S. (1993) A potential antipsychotic nature of NE-100, a novel sigma receptor antagonist: Preclinical neuropharmacological profiles. Soc. Neurosci. Abstr. 19: 598.
154. OKUYAMA, S., IMAGAWA, I., SAKAGAWA, T., NAKAZATO, A., YAMAGUCHI, K., KATOH, M., YAMADA, S., ARAKI, H. and OTOMO, S. (1994) NE-100, A novel sigma receptor ligand: effect on phencyclidine-induced behaviors in rats, dogs and monkeys. Life Sci. 55: 133-138
155. OKUYAMA, S., OGAWA, S., NAKAZATO, A. and TOMIZAWA, K. (1995) Effect of NE-100, a novel sigma receptor ligand, on phencyclidine-induced delayed cognitive dysfunction in rats. Neurosci. Lett. 189: 60-62.
156. 3 receptors in rodent brain. Soc. Neurosci. Abstr. 21: 1610.
157. 2-PAT. Soc. Neurosci. Abstr. 20: 748.
158. PARADA-TURSKA, J. and TURSKI, W.A. (1990) Excitatory amino-acids antagonists and memory: Effects of drugs acting at N-methyl-D-aspartate receptors in learning and memory tasks. Neuropharmacology 29: 1111-1116.
159. PAUL, I.A., BASILE, A.S., ROJAS, E., YOUDIM, M.B.H., DE COSTA, B., SKOLNICK, P., POLLARD, H.B. and KUIJPERS, G.A.J. (1993) Sigma receptors modulate nicotinic receptor function in adrenal chromaffin cells. FASEB J. 7: 1171-1178.
160. PAUL, I.A., ROJAS, E., YOUDIM, M.B.H., DE COSTA, B.R., SKOLNICK, P., POLLARD, H.B. and KUIJPERS, G.A.J. (1992) Sigma receptors modulate nicotinic receptor function in adrenal chromaffin cells. In: Multiple Sigma and PCP Receptor Ligands: Mechanisms for Neuromodulation and Neuroprotection?, J.M. Kamenka and E.F. Domino (Eds.), pp 527-541, NPP Books, Ann Arbor, MI.
161. PAUL, S.M. and PURDY, R.H. (1992) Neuroactive steroids. FASEB J. 6: 2311-2322.
162. PAUWELS, P.J., VAN ASSOUW, H.P., PEETERS, L., MOEREMANS, M. and LEYSEN, J.E. (1992) Chronic treatment with sabeluzole protects cultured rat brain
163. POIGNET, H., NOWICKI, J.P. and SCATTON, B. (1992) Lack of neuroprotective effect of some a ligands in a model of focal cerebral ischemia in the mouse. Brain Res. 596: 320-324.
164. PONTECORVO, M.J., KARBON, E.W., GOODE, S., CLISSOLD, D.B., BORODSKY, S.A., PATCH, R.J. and FERKANY, J.W. (1991) Possible cerebroprotective and in vivo NMDA antagonist activities of sigma agents. Brain Res. Bull. 26: 461-465.
165. QUIRION, R., BOWEN, W.D., ITZHAK, Y., JUNIEN, J.L., MUSACCHIO, J.M., ROTHMAN, R.B., SU, T.P., TAM, S.W. and TAYLOR, D.P. (1992) A proposal for the classification of sigma binding sites. Trends Pharmacol. Sci. 13: 85-86.
166. QUIRION, R., CHICHEPORTICHE, R., CONTRERAS, P.C., JOHNSON, K.M., LODGE, D., TAM, S.W., WOODS, J.H. and ZUKIN, S.R. (1987) Classification and nomenclature of phencyclidine and sigma receptor sites. Trends Pharmacol. Sci. 10: 444-446.
167. RAO, T.S., CLER, J.A., EMMETT, M.R., MICK, S. and WOOD, P.L. (1990a) BMY-14802 antagonizes harmaline and D-serine-induced increases in mouse cerebellar cyclic GMP: Neurochemical evidence for a σ receptor-mediated functional modulation of responses mediated by the N-methyl-D-aspartate receptor complex. Mol. Pharmacol. 37: 978-982.
168. RAO, T.S., CLER, J.A., MICK, S., RAGAN, D.M., LANTHORN, T.H., CONTRERAS, P.C., IYENGAR, S. and WOOD, P.L. (1990b) Opipramol, a potent a ligand is an anti-ischemic agent: Neurochemical evidence for an interaction with the N-methyl-D-aspartate receptor complex in vivo by cerebellar cGMP measurement. Neuropharmacology 29: 1199-1204.
169. RAO, T.S., MICK, S.J., CLER, J.A., EMMETT, M.R., DILWORTH, V.M., CONTRERAS, P.C., GRAY, N.M., WOOD, P.L. and IYENGAR, S. (1991) Effects of sigma ligands on mouse cerebellar cyclic guanosine monophosphate (cGMP) levels in vivo: Further evidence for a functional modulation of N-methyl-D-aspartate (NMDA) receptor complex-mediated events by sigma ligands. Brain Res. 561: 43-50.
170. ROBERTS, E., BOLOGA, L., FLOOD, J.F. and SMITH, G.E. (1987) Effects of dehydroepiandrosterone and its sulfate on brain tissue in culture and on memory in mice. Brain Res. 406: 357-362.
171. 3H]noradrenaline uptake in brain synaptosomes and adrenal chromaffin cells. Br. J. Pharmacol. 103: 1917-1922.
172. ROMAN, F.J., PASCAUD, X., BRUNELLE, G., MARTIN, B. and JUNIEN, J.L. (1992) Effect of JO-1784, a potent and specific sigma ligand, on cholinergic function. In: Multiple Sigma and PCP Receptor Ligands: Mechanisms for Neuromodulation and Neuroprotection?, J.M. Kamenka and E.F. Domino (Eds.), pp 555-562, NPP Books, Ann Arbor, MI.
173. ROMAN, F.J., PASCAUD, X., DUFFY O. and JUNIEN, J.L. (1991) Modulation by neuropeptide Y and peptide YY of NMDA effects in hippocampal slices: Role of sigma receptors. In: NMDA Related Agents: Biochemistry, Pharmacology and Behavior, T. Kameyama, T. Nabeshima and E.F. Domino (Eds.), pp 211-218, NPP Books, Ann Arbor, MI.
174. ROMAN, F.J., PASCAUD, X., MARTIN, B., VAUCHE, D. and JUNIEN, J.L. (1990) JO1784, A potent and selective ligand for rat and mouse brain a sites. J. Pharm. Pharmacol. 42: 439-440.
175. ROSS, S.B. (1991) Heterogeneous binding of σ radioligands in the rat brain and liver: Possible relationship to subforms of cytochrome P-450. Pharmacol. Toxicol. 68: 293-301.
176. ROTH, J.E., FRANKLIN, P.H. and MURRAY, T.F. (1993) The σ receptor ligand 1,3-di(2-tolyl)guanidine is anticonvulsant in the rat prepiriform cortex. Eur. J. Pharmacol. 236: 327-331.
177. ROTHMAN, R.B., BYKOV, V., NEWMAN, A., JACOBSON, A.E. and RICE, K.R. (1988) Interaction of enantiomeric pairs of opiate with phencyclidine binding sites in rat brain: Identification of (+)-pentazocine as a ligand potentially suitable for imaging sigma sites using positron emission tomography. Neuropeptides 12: 1-5.
178. 3H]-Ifenprodil, a novel NMDA antagonist, to a polyamine-sensitive site in the rat cerebral cortex. Eur. J. Pharmacol. 176: 249-250.
179. SCHUSTER, D.I., EHRLICH, G.K. and MURPHY, R.B. (1994) Purification and partial amino acid sequence of a 28kDa cyclophilin-like component of the rat liver sigma receptor. Life Sci. 55: 151-156.
180. SCHWARTZ, S., POHL, P. and ZHOU, G.Z. (1989) Steroid binding at σ-"opioid" receptors. Science 246: 1635-1637.
181. SINISCALCHI, A., CRISTOFORI, P. and VERATTI, E. (1987) Influence of N-allylnormetazocine on acetylcholine release from brain slices: Involvement of muscarinic receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 336: 425-429.
182. SKEEN, G.A., TWYMAN, R.E. and WHITE, H.S. (1993) The dihydropyridine nitrendipine modulates N-methyl-D-aspartate receptor channel function in mammalian neurons. Mol. Pharmacol. 44: 443-450.
183. SMITH, G. (1978) Animals models of Alzheimer's disease: Experimental cholinergic denervation. Brain Res. Rev. 13: 103-118.
184. SNELL, L.D. and JOHNSON, K.M. (1986) Characterization of the inhibition of excitatory amino acid-induced neurotransmitter release in the rat striatum by phencyclidine-like drugs. J. Pharmacol. Exp. Ther. 238: 938-946.
185. STEINFELS, G.F., ALBERICI, G.P., TAM, S.W. and COOK, L. (1988) Biochemical, behavioral, and electrophysiologic actions of the selective sigma receptor ligands (+)-pentazocine. Neuropsychopharmacology 1: 321-327.
186. STEINFELS, G.F., TAM, S.W. and COOK, L. (1989) Electrophysiological effects of selective σ receptor agonists, antagonists, and the selective phencyclidine receptor agonist MK-801 on midbrain dopamine neurons. Neuropsychopharmacology 2: 201-207.
187. STEPHANS, S.E. and YAMAMOTO, B.K. (1994) Methamphetamine-induced neurotoxicity: Roles for glutamate and dopamine efflux. Synapse 17: 203-209.
188. SU, T.P. (1991) σ Receptors - Putative links between nervous, endocrine, and immune systems. Eur. J. Biochem. 200: 633-642.
189. SU, T.P., LONDON, E.D. and JAFFE, J.H. (1988) Steroid binding atσreceptors suggests a link between endocrine, nervous, and immune systems. Science 240: 219-221.
190. SUMMERS, W.K., MAJOVSKI, L.V., MARSH, G.M., TACHIKI, K. and KLING, A. (1986) Oral tetrahydroaminoacridine in long-term treatmentof senile dementia, Alzheimer type. New Engl. J. Med. 315: 1241-1243.
191. SWANSON, L.W., TEYLER, T.J. and THOMPSON, R.F. (1982) Hippocampal long-term potentiation: mechanisms and implications for memory. Neurosci. Res. Prog. Bull. 20: 613-719.
192. TAKEDA, T., HOSOKAWA, M., TAKESHITA, S., IRINO, M., HIGUCHI, K., MATSUSHITA, T., TOMITA, Y., YASUHIRA, K., HAMAMOTO, H., SHIMIZU, K., ISHII, M. and YAMAMURO, T. (1981) A new murine model of accelerated senescence. Mech. Ageing Dev. 17: 183-194.
193. 3H]haloperidol binding in guinea pig brain membranes. Proc. Natl. Acad. Sci. USA 81: 5618-5621.
194. TAYLOR, D.P. and DEKLEVA, J. (1987) Potential antipsychotic BMY-14802 selectively binds to sigma sites. Drug Dev. Res. 11: 65-70.
195. TAYLOR, D.P., EISON, M.S., MOON, S.L. and YOCCA, F.D. (1991) BMY-14802: A potential antipsychotic with selective affinity for σ-binding sites. Adv. Neuropsychiat. Psychopharmacol. 1: 307-315.
196. TAYLOR, D.P., YEVICH, J.P., DEXTRAZE, P., MOON, S.L., BEHLING, S.H., DEFNET, J. and GEISSLER, M. (1992) Sigma ligands: A role in neuroprotection? In: Multiple Sigma and PCP Receptor Ligands: Mechanisms for Neuromodulation and Neuroprotection?, J.M. Kamenka and E.F. Domino (Eds.), pp 767-778, NPP Books, Ann Arbor, MI.
197. TERLECKYJ, I. and SONSALLA, P.K. (1994) The sigma receptor ligand (-)-BMY-14802 prevents methamphetamine-induced dopaminergic neurotoxicity via interactions at dopamine receptors. J. Pharmacol. Exp. Ther. 269: 44-50.
198. TORTELLA, F.C., WITKIN, J.M., and MUSACCHIO, J.M. (1988) Caramiphen: A non-opioid with potent anticonvulsant propertiesin rats. Eur. J. Pharmacol. 155: 69-75.
199. UJIKE, H., KANZAKI, A., OKUMURA, K., AKIYAMA, K. and OTSUKI, S. (1992a) Sigma (σ) antagonist BMY-14802 prevents metamphetamine-induced sensitization. Life Sci. 50: 129-134.
200. UJIKE, H., OKUMURA, K., ZUSHI, Y., AKIYAMA, K. and OTSUKI, S. (1992b) Persistent supersensitivity of σ receptors develops during repeated metamphetamine treatment. Eur. J. Pharmacol. 211: 232-328.
201. UJIKE, H., TSUCHIDA, K., AKIYAMA, K. and OTSUKI, S. (1992c) Supersensitivity of σ receptors after repeated administration of cocaine. Life Sci. 50: 1673-1681.
202. VENABLE, N. and KELLY, P.H. (1990) Effects of NMDA receptor antagonists on passive avoidance learning and retrieval in rats and mice. Psychopharmacology 100: 215-221.
203. VILNER, B.J. and BOWEN, W.D. (1995) Dual modulation of cellular calcium by sigma receptor ligands: Release from intracellular stores and blockade of voltage-dependent influx. Soc. Neurosci. Abstr. 21: 1608.
204. WALKER, J.M., BOWEN, W.D., WALKER, F.O., MATSUMOTO, R.R., DeCOSTA, B. and RICE, K.C. (1990) Sigma receptors: Biology and function. Pharmacol. Rev. 42: 355-402.
205. WALKER, J.M., MATSUMOTO, R.R., BOWEN, W.D., GANS, D.L., JONES, K.D. and WALKER, F.O. (1988) Evidence for a role of haloperidol-sensitive σ-'opiate' receptors in the motor effects of antipsychotic drugs. Neurology 28: 961-965.
206. WHITEHOUSE, L. (1965) The effects of physostigmine on discrimination learning. Psychopharmacologia 9: 319-322.
207. WU, F.S., GIBBS, T.T. and FARB, D.H. (1991a) Pregnenolone sulfate: A positive allosteric modulator at the N-methyl-D-aspartate receptor. Mol. Pharmacol. 40: 333-336.
208. WU, X.Z., BELL, J.A., SPIVAK, C.E., LONDON, E.D. and SU, T.P. (1991b) Electrophysiological and binding studies on intact NCB-20 cells suggest presence of a low affinity σ receptor. J. Pharmacol. Exp. Ther. 257: 351-359.
209. YAGI, H., KATOH, S., AKIGUCHI, I. and TAKEDA, T. (1988) Age-related deterioration of ability of acquisition in memory and learning in senescence accelerated mouse: SAM-P/8 as an animal model of disturbances in recent memory. Brain Res. 474: 86-93.
210. YAMADA, M., NISHIGAMI, T., NAKASHO, K., NISHIMOTO, Y. and MIYAJI, H. (1994) Relationship between sigma-like site and progesterone-binding site of adult male rat liver microsomes. Hepatology 20: 1271-1280.
211. 1 site. J. Neurosci. 15: 731-736.
212. 2+ channels by adenosine autoreceptors. Nature 365: 256-258.
213. YEVICH, J.P., DEXTRAZE, P., TAYLOR, D.P. and MOON, S.L. (1994) Synthesis and evaluation of N-substituted 1-(5-fluoro-2-pyrimidinyl)piperazine derivatives as potential anti-ischemic agents. Bioor. Med. Chem. Lett. 4: 1941-1946.
214. 3H]noradrenaline in brain slices of senescence-accelerated mouse. Int. J. Dev. Neurosci. 8: 267-272.
215. 3H]acetylcholine release from brain slices of senescence-accelerated mouse. Int. J. Dev. Neurosci. 10: 121-129.